Lexaria Bioscience (LEXX) Other Working Capital Changes (2010 - 2026)
Lexaria Bioscience's (LEXX) quarterly Other Working Capital Changes came in at $8400.0 in Q1 2026, down 97.93% year-on-year from $406265.0 in Q1 2025, and up 839900.0% quarter-over-quarter from $1.0 in Q3 2025.
Lexaria Bioscience (LEXX) Other Working Capital Changes (2010 - 2026) Analysis & Trends
Lexaria Bioscience has disclosed Other Working Capital Changes across 17 years of filings, most recently posting $8400.0 for Q1 2026.
- Other Working Capital Changes for Q1 2026 came in at $8400.0, down 97.93% year-over-year; the trailing twelve-month figure through Feb 2026 was $8400.0 (up 102.27% YoY), and the FY2025 annual result was $47001.0, up 241.26% from the prior year.
- Other Working Capital Changes came in at $8400.0 for Q1 2026 at Lexaria Bioscience, up from $1.0 in the prior quarter.
- In the past five years, Other Working Capital Changes ranged from a high of $573589.0 in Q1 2023 to a low of -$743696.0 in Q4 2024.
- The 5-year median for Other Working Capital Changes is -$3195.5 (2024), against an average of $3262.2.
- Across the five-year window, Other Working Capital Changes plunged 396.78% in 2022 and surged 1336.81% in 2025, its largest moves.
- Lexaria Bioscience's Other Working Capital Changes stood at -$316419.0 in 2022, then plunged by 30.99% to -$414472.0 in 2023, then slumped by 79.43% to -$743696.0 in 2024, then jumped by 100.0% to $1.0 in 2025, then soared by 839900.0% to $8400.0 in 2026.
- The last three Other Working Capital Changes figures came in at $8400.0 (Q1 2026), $1.0 (Q3 2025), and $332468.0 (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - |
| 10 | Lexaria Bioscience | 7.17 Mn | 1.65 Mn | 20,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2026 | 8,400.00 |
| Feb 28, 2026 | 8,400.00 |
| Aug 31, 2025 | 1.00 |
| Aug 31, 2025 | 1.00 |
| May 31, 2025 | 332,468.00 |
| May 31, 2025 | 332,468.00 |
| Feb 28, 2025 | 406,265.00 |
| Feb 28, 2025 | 406,265.00 |
| Nov 30, 2024 | -743,696.00 |
| Nov 30, 2024 | -743,696.00 |
| Aug 31, 2024 | -6,392.00 |
| Aug 31, 2024 | -6,392.00 |
| May 31, 2024 | -26,881.00 |
| May 31, 2024 | -26,881.00 |
| Feb 29, 2024 | 414,472.00 |
| Feb 29, 2024 | 414,472.00 |
| Nov 30, 2023 | -414,472.00 |
| Nov 30, 2023 | -414,472.00 |
| Aug 31, 2023 | -52,979.00 |
| Aug 31, 2023 | -52,979.00 |